Profile data is unavailable for this security.
About the company
Lumiera Health Inc. is a Canadian company that specializes in developing and commercializing consumer products for the natural health industry. Through its Holizen Laboratories division, the Company offers a diverse portfolio of herbal tonics and natural supplements, including a line of sleep aids. Additionally, the Company is introducing a topical product line that targets the endocannabinoid system without using cannabis, providing a solution for chronic pain and inflammation. Its brands also include Awaye and Bazzzics. Awaye is a topical product that works with the body's own endocannibinoid pain defense system and provides relief from both acute and chronic pain. Part of the Holizen portfolio, Bazzzics is a line of three formulas composed of sedative plant extracts that can be combined to address the customer's specific sleeping needs: pre-sleep serenity, fall asleep, and stay asleep.
- Revenue in CAD (TTM)592.62k
- Net income in CAD-2.36m
- Incorporated2013
- Employees--
- LocationLumiera Health Inc4500 Blvd. KimberSAINT-HUBERT J3Y 8K5CanadaCAN
- Phone+1 (450) 926-2442
- Fax+1 (450) 926-2452
- Websitehttps://www.lumiera.ca/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aequus Pharmaceuticals Inc | 918.47k | -656.34k | 663.17k | 12.00 | -- | -- | -- | 0.722 | -0.005 | -0.005 | 0.0069 | -0.052 | 1.74 | 7.59 | 7.95 | -- | -124.52 | -97.48 | -- | -- | 56.95 | -- | -71.46 | -148.91 | 0.027 | -2.08 | -- | -- | 129.20 | -18.58 | 26.55 | -- | -- | -- |
| Lumiera Health Inc | 592.62k | -2.36m | 845.13k | -- | -- | -- | -- | 1.43 | -0.0139 | -0.0139 | 0.0035 | -0.0136 | 0.5096 | 2.13 | 11.78 | -- | -202.92 | -- | -- | -- | 13.17 | -- | -398.18 | -- | 0.0395 | -2.10 | -- | -- | 46.91 | -- | -188.58 | -- | -- | -- |
| Genix Pharmaceuticals Corp | 0.00 | -335.05k | 1.22m | -- | -- | -- | -- | -- | -0.0056 | -0.0056 | 0.00 | -0.0232 | 0.00 | -- | -- | -- | -694.12 | -62.81 | -- | -112.52 | -- | -- | -- | -45,916.77 | -- | -0.8825 | -- | -- | -100.00 | -- | -357.73 | -- | -- | -- |
| Vitality Products Inc | 870.37k | -48.94k | 1.24m | -- | -- | -- | -- | 1.43 | -0.0012 | -0.0012 | 0.021 | -0.0364 | 1.29 | 2.40 | 7.61 | -- | -7.23 | -30.11 | -- | -- | 72.08 | 73.52 | -5.62 | -42.71 | 0.1486 | -- | -- | -- | 0.705 | 5.10 | 45.71 | -- | -- | -- |
